A variety of evidence showed that the extracellular serine protease inhibitor SERPINE2 fosters the metastasis of breast cancer cells by remodeling the extracellular matrix [19, 20, 46, 47]. The gene discussed is SERPINE2; the disease is breast carcinoma.